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Water-soluble arene ruthenium catalysts containing sulfonated diamine
ligands for asymmetric transfer hydrogenation of a-aryl ketones and imines
in aqueous solution
Je´roˆme Canivet and Georg Su¨ss-Fink*
A new family of nine cationic organometallic aqua complexes of the type [(arene)Ru(RSO2 N>NH2 )(OH2 )]
+ (1–9), containing
chiral N,N-chelating ligands, has been synthesised and isolated as the tetrafluoroborate salts, which are water-soluble and
stable to hydrolysis. The enantiopure complexes 1–9 catalyse the transfer hydrogenation of prochiral aryl ketones and imines in
aqueous solution to give the corresponding alcohols and amines with good conversion and enantioselectivity. This method gives
an environmentally friendly access, for instance, to isoquinoline alkaloids by asymmetric catalysis in water.
Introduction
Water-soluble organometallic complexes attract continuously
growing interest for applications in catalysis, because of
environmentally friendly processing, simple product separa-
tion and pH dependent selectivity in aqueous media. The
chemistry of organometallic aqua ions was comprehensively
reviewed by Koelle.1 Related reviews deal with water-soluble
organometallics complexed by hydrophilic ligands,2 metal-
mediated organic synthesis in water3 and catalysis by water-
soluble organometallic complexes in biphasic systems.4 In
particular, the transfer hydrogenation of ketones and imines in
organic solvents is a powerful tool for asymmetric synthesis
which was pioneered by Noyori,5–7 Morris,8 Bullock9 and
Ba¨ckvall.10 Several recent reports deal with asymmetric
transfer hydrogenation of ketones with formate in aqueous
media using active catalytic systems based on N-(p-toluene-
sulfonyl)-1,2-diphenylethylenediamine and derivatives,11–16 or
on aromatic proline amides derivatives.17 These catalytic
systems show good activities and enantioselectivities, but
the catalysts are formed in situ from precursors and have
not been isolated.
Recently we reported the synthesis of arene ruthenium
chloro complexes, [(arene)Ru(L1)Cl] (L1H = (R,R)-N-(p-tolue-
nesulfonyl)diaminocyclohexane), which catalyse the transfer
hydrogenation of acetophenone in aqueous solution using
formate as the hydrogen source, with a TOF of 43 h21
and enantiomeric excess of 93%.18 Moreover, the known 2-S-
(p-toluenesulfonylamino)methylpyrrolidine (L2H) and 2-S-
(2,4,6-triisopropyl-benzenesulfonylamino)methylpyrrolidine
(L3H) ligands show, in combination with p-cymene ruthenium
dichloro dimer, a slight activity and selectivity for the same
reaction in isopropanol.19
Whereas the enantioselective transfer hydrogenation of CLO
double bonds is well-known, the same reaction for the CLN
double bonds is much less studied. There are several reports on
the enantioselective transfer hydrogenation of imines, particu-
larly of derivatives of 3,4-dihydroisoquinoline, using catalytic
systems based on N-(p-toluenesulfonyl)-1,2-diphenylethylene-
diamine and derivatives in combination with ruthenium or
rhodium precursors in azeotropic formic acid–triethylamine to
give the corresponding chiral amine, with TOFs between 20
and 30 h21 and more than 95% for enantiomeric excess.20–23
More recently, Wu et al. reported, for the same reaction,
similar catalytic systems involving a surfactant in aqueous
solution, with sodium formate as the hydrogen source, with
enantiomeric excesses greater than 96%.24
Herein, we report the synthesis of water-soluble arene
ruthenium complexes containing enantiopure chiral mono-
sulfonated diamine ligands, including the new ligand S-2-
(S-camphor-10-sulfonylamino)methylpyrrolidine, and their
catalytic potential for the asymmetric transfer hydrogenation
of aromatic ketones and imines in aqueous solution using
sodium formate as the hydrogen source.
Results
Synthesis of cationic arene ruthenium complexes containing
chiral sulfonated diamine ligands
The arene ruthenium chloro complexes [(arene)Ru(L1)Cl],
containing a chiral bidentate ligand derived from L1H =
N-tosyl-trans-1,2-diaminocyclohexane, which have been
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reported recently,18 react in aqueous solution with silver
sulfate to give, with precipitation of silver chloride, the corres-
ponding cationic aqua complexes [(arene)Ru(L1)(OH2)]
+
(1: arene = C6H6, 2: arene = p-MeC6H4
iPr, 3: arene =
C6Me6), which can be isolated from the filtered solution, upon
addition of NaBF4, as the tetrafluoroborate salts (eqn (1)).
[(arene)Ru(L1)Cl] + Ag+ + H2O A
[(arene)Ru(L1)(OH2)]
+ + AgCl
(1)
On the other hand, the L2 and L3 analogues
[(arene)Ru(L2)(OH2)]
+ (4: arene = C6H6, 5: arene =
p-MeC6H4
iPr, 6: arene = C6Me6) and [(arene)Ru(L
3)(OH2)]
+
(7: arene = C6Me6) are accessible from the corresponding
arene ruthenium triaqua complexes and L2H and L3H,
according to eqn (2). All cationic aqua complexes can be
isolated from the filtered solution, upon addition of NaBF4, as
the stable tetrafluoroborate salts.
[(arene)Ru(OH2)3]
2+ + LH A
[(arene)Ru(L)(OH2)]
+ + H3O
+ + H2O
(2)
Moreover, we synthesised a new representative of the series
of chiral (sulfonylamino)methylpyrrolidine ligands, which
contains a second chiral centre in the sulfonyl moiety:
Thus, 2-S-(S-camphor-10-sulfonylamino)methylpyrrolidine
(L4H) was obtained by reacting the N-Boc protected
S-2-aminomethylpyrrolidine (Boc = t-butyl carbonate) with
S-Camphor-10-sulfonyl chloride, followed by deprotection
with trifluoroacetic acid. (Scheme 1)
The new enantiopure L4H reacts in the same way (eqn (2)) as
L2H or L3H with arene ruthenium triaqua complexes
[(arene)Ru(OH2)3]
2+ to give the cations [(arene)Ru(L4)
(OH2)]
+ (8: arene = p-MeC6H4
iPr, 9: arene = C6Me6), which
precipitate from the aqueous solution as tetrafluoroborate
salts upon saturation with NaBF4.
All compounds [(arene)Ru(L)(OH2)][BF4] (containing
cations 1–9), are air-stable, orange-yellow and water-soluble
powders, which have been fully characterised by 1H and
13C NMR spectroscopy, mass spectroscopy and elemental
analysis (see Experimental). The systematic variation of the
substituents in both the arene and the sulfonated diamine
ligands allows us to study in detail the steric and electronic
influence on the catalytic activities and selectivities of these
complexes for transfer hydrogenation reactions.
Enantioselective transfer hydrogenation of aryl ketones in water
The synthesis of chiral alcohols from the corresponding
prochiral ketones by enantioselective transfer hydrogenation
has a great potential, particularly if the reaction can be carried
out in water using sodium formate as the hydrogen
source.11,14,18,25–27 Recently we found the chloro complexes
[(arene)Ru(L1)Cl] were able to catalyse the transfer hydro-
genation of acetophenone to give enantioselectively phenyl-
ethanol; in the case of arene = C6Me6, the aqua complex
[(arene)Ru(L1)(OH2)]
+ (3) could be identified as a catalytically
active species.18 As expected, all aqua complexes 1–9 are active
catalysts for the enantioselective transfer hydrogenation of
various prochiral aryl ketones (A1 = acetophenone, A2 =
a-tetralone, A3 = 1-indanone, see Scheme 2) to give the
corresponding chiral aryl alcohols with enantioselectivities up
to 94% (Table 1). All reactions are found to be quantitative
(TON . 99) after 2 to 5 h.
As Table 1 reveals, the best results, as far as both catalytic
activity and enantioselectivity are concerned, have been
obtained with the aqua complex 3 as the catalyst, the turnover
frequencies varying from 25 to 44 h21 and the enantiomeric
excess attaining 93 to 94% (entries 3, 12 and 20). For the
hydrogenation of A1 (entries 1–9), the diaminocyclohexane
complexes 1 to 3 show a more than two times better
enantioselectivity than the 2-methylaminopyrrolidine com-
plexes 4 to 9, which contain less rigid ligands. This difference
Scheme 1 (i) S-Camphor-10-sulfonyl chloride, Et3N. (ii) CF3COOH.
Scheme 2 Enantioselective transfer hydrogenation of aryl ketones A1,
A2 and A3 catalysed by aqua complexes 1–9 in water.
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increases with the backbone rigidity of the substrate, as found
for A2 (entries 12 and 15) and A3 (entries 20 and 22). As far as
catalytic activity is concerned, all aqua complexes 1–9 show
comparable TOF values for one given substrate. However, the
catalytic activities differ substantially with changing substrate:
the more rigid substrates A2 and A3 are hydrogenated slower
than the more flexible A1. The substitution pattern of the
chiral ligand L or an additional chiral centre in 1–9 has no
significant influence on the catalytic activity.
The pH dependence of both, catalytic activity and enantio-
selectivity of the transfer hydrogenation reaction has been
studied in the case of substrate A1 and catalyst 6. Fig. 1 shows
the conversion and ee profiles in the pH range from 5 to 10.
While enantioselectivity is almost independent of the pH, the
highest activity was found for pH = 9.
Enantioselective transfer hydrogenation of aryl imines in water
The aqua complexes [(arene)Ru(L)(OH2)]
+ (1–9) are also
found to catalyse the enantioselective transfer hydrogenation
of aryl imines in aqueous solution, using sodium formate as
the hydrogen source. This catalytic reaction, so far much less
studied than the transfer hydrogenation of ketones, works with
1–9 for the prochiral substrates phenyl-N-(1-phenylethylidene)
methanamine (A4), 1-methyl-6,7-dimethoxy-3,4-dihydroiso-
quinoline (A5) and 1-(5-chloro-2-nitrophenyl)-6,7-dimethoxy-
3,4-dihydroisoquinoline (A6), see Scheme 3. This is particularly
interesting in the case of A5, because the product R-salsolidine
and its derivatives are valuable intermediates in the synthesis
of alkaloid drugs showing antibacterial effects28,29 or being
active in neurodisease treatment.30
The results are compiled in Table 2. In all cases, the best
results are obtained with the p-cymene and hexamethylbenzene
complexes containing the chiral ligand L1 (2 and 3); while the
differences in the catalytic activities are less pronounced, the
enantioselectivities differ more markedly. All reactions are
found to be quantitative (TON . 99) after 2 to 5 h.
The pH-dependence of catalytic activity and enantioselec-
tivity, studied in the case of substrate A5 and catalyst 5, in the
pH range from 7 to 12 (Fig. 2), also shows an activity
maximum at pH = 9, while the enantioselectivity is almost not
influenced by the pH, in line with the findings for aryl ketones.
Discussion
In all catalytic reactions reported herein, the transfer hydro-
genation of aryl ketones or of aryl imines in aqueous solution
using sodium formate as hydrogen source, the catalytically
active aqua complexes [(arene)Ru(L)(OH2)]
+ can be recovered
unchanged after the catalytic run as tetrafluoroborate salts.
Based on the observation of an intermediary hydrido complex
in the case of the transfer hydrogenation of acetophenone
catalysed by the non-chiral ortho-phenanthroline (phen)
complex [(C6Me6)Ru(phen)(OH2)]
2+,31 and the X-ray-crystal-
lographic characterisation of the bipyridine (bipy) analogue
Table 1 Enantioselective transfer hydrogenation of aryl ketones A1,
A2 and A3 by aqua complexes 1–9 in watera
Entry Catalyst Substrate TOF/h21 b,c ee (%)b
1 1 A1 48 51
2 2 A1 45 83
3 3 A1 44 93
4 4 A1 34 25
5 5 A1 37 23
6 6 A1 43 39
7 7 A1 40 38
8 8 A1 39 44
9 9 A1 38 30
10 1 A2 15 91
11 2 A2 37 84
12 3 A2 25 94
13 4 A2 15 48
14 5 A2 24 23
15 6 A2 19 13
16 7 A2 25 11
17 8 A2 28 21
18 9 A2 25 14
19 2 A3 35 70
20 3 A3 35 93
21 5 A3 21 30
22 6 A3 28 13
a Conditions: H2O (5 mL), A (1 mmol), ratio catalyst/substrate/
formate = 1/100/500, 60 uC, pH = 9, 2 h. b Determined by chiral
HPLC analysis. c Turnover frequencies determined after 30 minutes
and expressed in mol of product/(mol of Ru 6 h).
Fig. 1 pH-dependent profile of conversion (n) and enantiomeric
excess (%) for the transfer hydrogenation of acetophenone A1 (1 mmol)
using 6 as catalyst and HCOONa as hydrogen donor in water (5 mL),
at 60 uC, for 2 h, the catalyst/substrate/formate ratio being 1/100/500.
Scheme 3 Enantioselective transfer hydrogenation of aryl imines A4,
A5 and A6 catalysed by aqua complexes 1–9 in water.
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[(C6Me6)Ru(bipy)H][CF3SO3],
32 and based on the pioneering
mechanistic work of Noyori, with [(arene)Ru(TsNCHPh-
CHPhNH2)Cl],
6,7,33,34 Morris,8 and Wills,35 we propose the
catalytic cycle outlined in Scheme 4 (for the example of
complex 6) as a mechanistic description of the catalytic action
of the aqua complexes 1–9 in the transfer hydrogenation of
aryl ketones and imines.
Interestingly, we observed that all prochiral aryl ketones and
imines preferentially yield, with 1–9, the R enantiomer of
the corresponding chiral alcohols or amines, although the
configuration of the chiral ligands is not the same: R,R-L1 in
1–3, S-L2 in 4–6, S-L3 in 7 and S,S-L4 in 8 and 9. This can be
rationalised in terms of CH/p interactions36 between the
hydrogen atoms of the arene ligand of the ruthenium complex
and the aryl substituent of the substrate in the hydrogen
bridged transition state (see Scheme 4, bottom). In all cases,
the chiral ligand L (R, R-L1, S-L2, S-L3, S, S-L4) orients the Si
face of the prochiral carbon atom of the substrate towards the
ruthenium centre (Scheme 5).
Conclusion
In conclusion, we report herein the synthesis of nine water-
soluble chiral arene ruthenium aqua complexes containing
Fig. 2 pH-dependent profile of conversion (n) and enantiomeric
excess (%) for the transfer hydrogenation of acetophenone A5 (1 mmol)
using 5 as catalyst and HCOONa as hydrogen donor in water (5 mL),
at 60 uC, for 2 h, the catalyst/substrate/formate ratio being 1/100/500.
Scheme 4 Postulated catalytic cycle for the enantioselective transfer
hydrogenation of imines using [6]BF4 as catalyst and sodium formate
as hydrogen source in aqueous solution.
Table 2 Enantioselective transfer hydrogenation of aryl imines A4, A5
and A6 by aqua complexes 1–9 in watera
Entry Catalyst Substrate TOF/h21 b,c ee (%)b
1 1 A4 54 48
2 2 A4 49 74
3 3 A4 51 91
4 4 A4 37 21
5 5 A4 40 48
6 6 A4 38 35
7 7 A4 32 29
8 8 A4 35 44
9 9 A4 29 32
10 1 A5 46 46
11 2 A5 50 88
12 3 A5 44 51
13 4 A5 46 21
14 5 A5 45 47
15 6 A5 45 44
16 7 A5 38 41
17 8 A5 41 45
18 9 A5 40 42
19 2 A6 24 61
20 3 A6 22 50
21 5 A6 18 25
22 6 A6 12 18
a Conditions: H2O (5 mL), A (1 mmol), ratio catalyst/substrate/
formate = 1/100/500, 60 uC, pH = 9, 2 h. b Determined by chiral
HPLC analysis. c Turnover frequencies determined after 30 minutes
and expressed in mol of product/(mol of Ru 6 h).
Scheme 5 CH/p interaction postulated between the arene ligand of
the ruthenium complexes and the aryl substituent of the prochiral
substrate, exemplified for two different cases.
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R,R-N-(p-toluenesulfonyl)diaminocyclohexane or S-2-(sulfo-
nyl-amino)methylpyrrolidine derivatives as chelating ligands.
All these complexes are found to effectively catalyse the
transfer hydrogenation of a-aryl ketones and a-aryl imines in
aqueous solution using formate as the hydrogen source,
without any additional surfactant. These catalytic reactions
involve CH/p interactions between the arene ligand of the
catalyst and the aryl substituent of the substrate, previously
reported by Noyori.36 Moreover, the transfer hydrogenation
of 1-methyl-6,7-dimethoxy-3,4-dihydroisoquinoline (A5) to
R-salsolidine with a TOF of 50 h21 and ee of 88% using
water-soluble complexes give an environmentally friendly
access to isoquinoline alkaloids by asymmetric catalysis in
aqueous solution.
Experimental
General remarks
All manipulations were carried out in an inert atmosphere
using standard Schlenk techniques and freshly distilled solvents
saturated with nitrogen prior to use. The starting dimers
[(arene)RuCl2]2
37 and the N-Boc-S-2-aminomethylpyrrolidine,
the S-2-[N-(4-toluenesulfonyl)aminomethyl]pyrrolidine (L2H)
and the S-2-[(N-(2,4,6-triisopropylbenzensulfonyl)amino-
methyl]pyrrolidine (L3H) were prepared according to the
published methods.19 The arene ruthenium chloro complexes,
[(arene)Ru(L1)Cl], were synthesised as previously reported.18
All other reagents were commercially available and were used
without further purification. NMR spectra were recorded on a
Bruker 400 MHz spectrometer. Electro-spray mass spectra
were obtained in positive- or negative-ion mode with an LCQ
Finnigan mass spectrometer. Microanalyses were carried out
by the Laboratoire de Chimie Pharmaceutique, Universite´ de
Gene`ve (Switzerland).
Synthesis of L4H
S-tert-butyl-2-(S-camphor-10-sulfonylamino)methylpyrrol-
idine-1-carboxylate. To a solution of S-tert-butyl-2-amino-
methylpyrrolidine-1-carboxylate (350 mg, 1.84 mmol) in
pyridine (20 mL) was added 1.5 equivalents of the
S-camphor-10-sulfonyl chloride (693 mg, 2.8 mmol) at 0 uC.
After 6 hours, Et2O (100 mL) was added and the organic layer
was washed with HCl 10% (2 6 30 mL), saturated NaHCO3
(2 6 30 mL) and saturated NaCl (30 mL). The resulting
yellowish oil was purified on a silica gel column (pentane–
ethylacetate = 3 : 1) to obtain the pure product as colourless
oil. (Yield: 65%, 485 mg). 1H NMR d (400 MHz, CDCl3,
21 uC): 0.85 (s, 3H), 1.02 (s, 3H), 1.21 (b, 1H), 1.43 (s, 9H),
1.82–2.13 (b, 9H), 2.84–2.91 (d, J = 15 Hz, 1H), 3.27–3.34
(b, 4H), 3.92 (b, 1H) ppm. 13C NMR d (200 MHz, CDCl3,
21 uC): 19.39 (CH3), 19.93 (CH3), 25.52 (CH2), 26.94 (CH2),
27.00 (CH2), 27.55 ((CH3)3), 28.81 (CH2), 31.58 (CH),
42.75 (C(CH3)2), 42.92 (CH2CO), 46.15 (CH2), 46.72
(CH2), 49.80 (CH2SO2), 58.06 (CH), 59.29 (CCH2), 79.88
(C(CH3)3), 170.65 (COO
tBu), 217.05 (CO) ppm. m/z
(ESI, negative ion) 413.6 [C20H33N2O5S
2]. (Found: C,
57.88; H, 8.24; N,6.71. C20H34N2O5S requires C, 57.94; H,
8.27; N, 6.76).
S-2-(S-camphor-10-sulfonylamino)methylpyrrolidine (L4H).
To a solution of S-tert-butyl-2-(S-camphor-10-sulfonylamino)
methyl-pyrrolidine-1-carboxylate (284 mg, 0.7 mmol) in dry
CH2Cl2 were added 10 equivalents of trifluoroacetic acid
(0.6 mL) at room temperature to give a dark yellowish
solution. After 8 hours, the organic layer was washed with
saturated NaHCO3 (2 6 50 mL) and saturated NaCl (2 6
30 mL). After evaporation, the residue was purified on silica
gel column (pentane–ethylacetate = 3 : 1) to give the desired
product L4H as colourless oil. (Yield: 60%, 130 mg). 1H NMR
d (400 MHz, CDCl3, 21 uC) = 0.91 (s, 3H), 1.05 (s, 3H), 1.25
(b, 1H), 1.72–2.07 (b, 9H), 2.78–2.86 (d, J = 16 Hz, 1H), 3.29–
3.32 (b, 4H), 3.91 (b, 1H) ppm. 13C NMR d (200 MHz, CDCl3,
21 uC) = 19.37 (CH3), 19.93 (CH3), 25.51 (CH2), 26.94 (CH2),
27.04 (CH2), 28.81 (CH2), 31.58 (CH), 42.75 (C(CH3)2), 42.88
(CH2CO), 46.17 (CH2), 46.70 (CH2), 49.84 (CH2SO2), 58.01
(CH), 59.32 (CCH2), 217.12 (CO) ppm. m/z (ESI, negative ion)
313.2 [C15H25N2O3S
2]. (Found: C, 57.38; H, 8.38; N, 9.08.
C15H26N2O3S requires C, 57.30; H, 8.33; N, 8.91).
Preparation of arene ruthenium aqua complexes 1–9
Method A for complexes 1 to 3. To a suspension of the
appropriate chloro complex [(arene)Ru(L1)Cl]18 (0.3 mmol) in
deionised water was added 2 equivalents of silver sulfate
(0.6 mmol, 187 mg). After stirring at room temperature in the
dark for 2 hours, the resulting orange solution was filtered
over celite. Then solid NaBF4 was added until saturation of
the solution, visible by the appearance of a yellow precipitate.
Then the suspension was centrifuged, the solid was dissolved in
10 ml of dry acetonitrile and filtered over celite to eliminate
the excess of NaBF4. After evaporation of the solvent, the
tetrafluoroborate salt was obtained as an orange-yellow
powder in good yields.
[(C6H6)Ru(L
1)(OH2)](BF4) ([1]BF4). (Yield: 70%, 116 mg).
1H NMR d (400 MHz, D2O, 21 uC) = 0.94(m, CH2), 1.23 (m,
2 CH2), 1.44 (m, CH), 1.58 (m, CH2), 1.86 (m, CH), 2.32 (s,
p-(CH3)C6H4SO2), 5.81 (s, C6H6), 7.15 (d, J = 7.1 Hz,
p-(CH3)C6H4SO2), 7.72 (d, J = 7.0 Hz, p-(CH3)C6H4SO2)
ppm. 13C NMR d (200 MHz, D2O, 21 uC) = 21.9 (p-(CH3)
C6H4SO2), 23.8 (CH2), 25.2 (CH2), 32.2 (CH2), 32.7 (CH2),
59.1 (CH), 60.5 (CH), 83.8 (C6H6), 127.8 (2 CH), 128.4 (2 CH),
138.1 (p-(CH3)C6H4SO2), 143.5 (p-(CH3)C6H4SO2) ppm. m/z
(ESI, positive ion) 465.1 [C19H27N2O3RuS
+]. (Found: C,
41.43; H, 5.08; N, 4.98. C19H27BF4N2O3RuS requires C,
41.39; H, 4.94; N, 5.08).
[(p-MeC6H4
iPr)Ru(L1)(OH2)](BF4) ([2]BF4). (Yield: 73%,
133 mg). 1H NMR d (400 MHz, D2O, 21 uC) = 1.11 (m,
CH2), 1.22 (m, 2 CH2), 1.30 (d, J = 7.2 Hz, (CH3)2CH), 1.55
(m, CH), 1.74 (m, CH2), 2.08 (m, CH), 2.34 (s, p-(CH3)
C6H4SO2), 2.92 (m, J = 7 Hz, (CH3)2CH), 5.62 (d, J = 6.2Hz,
C6H4), 5.78 (d, J = 6.3Hz, C6H4), 7.21 (d, J = 8 Hz,
p-(CH3)C6H4SO2), 7.75 (d, J = 8 Hz, p-(CH3)C6H4SO2) ppm.
13C NMR d (200 MHz, D2O, 21 uC) = 18.1 (CH3), 21.6
(CH(CH3)2), 22.1 (p-(CH3)C6H4SO2), 24.2 (CH2), 24.5 (CH2),
31.8 (CH(CH3)2), 33.4 (CH2), 34.1 (CH2), 57.8 (CH),
60.5 (CH), 87.2 (C6H4), 104.5 (C6H4), 108.3 (C6H4), 126.5
5
(p-(CH3)C6H4SO2), 129.4 (p-(CH3)C6H4SO2), 138.8 (p-(CH3)
C6H4SO2), 143.5 (p-(CH3)C6H4SO2) ppm. m/z (ESI, positive
ion) 521.1 [C23H35N2O3RuS
+]. (Found: C, 45.51; H, 5.98;
N, 4.58. C23H35BF4N2O3RuS requires C, 45.47; H, 5.81;
N, 4.61).
[(C6Me6)Ru(L
1)(OH2)](BF4) ([3]BF4). (Yield: 97%, 185 mg).
1H NMR d (400 MHz, D2O, 21 uC) = 1.12 (m, 2 CH2), 1.28 (m,
CH2), 1.31 (m, CH), 1.45 (m, CH2), 1.82 (m, CH), 2.24 (s,
C6(CH3)6), 2.51 (s, CH3), 7.34 (d, J = 7.3 Hz, C6H4), 7.84 (d,
J = 7.6 Hz, C6H4).
13C NMR d (200 MHz, D2O, 21 uC) = 16.8
(C6(CH3)6), 21.7 (p-(CH3)C6H4SO2), 24.3 (CH2), 34.1 (CH2),
34.8 (CH2), 57.5 (CH), 59.3 (CH), 91.7 (C6Me6), 127.4
(p-(CH3)C6H4SO2), 127.8 (p-(CH3)C6H4SO2), 138.1 (p-(CH3)
C6H4SO2), 142.8 (p-(CH3)C6H4SO2). m/z (ESI, positive ion)
549.2 [C25H39N2O3RuS
+]. (Found: C, 47.41; H, 6.31; N, 4.32.
C25H39BF4N2O3RuS requires C, 47.25; H, 6.19; N, 4.41).
Method B for complexes 4 to 9. To a suspension of the
appropriate dimer [(arene)RuCl2]2 (0.15 mmol) in deionised
water was added 2 equivalents of silver sulfate (0.6 mmol,
187 mg). After stirring at room temperature in the dark for
2 hours, the resulting yellow solution was filtered and then
added to 0.4 mmol of L2H, L3H or L4H under inert
atmosphere. Then the solution was allowed to react at room
temperature for 2 hours, during this time the solution
darkened. Then solid NaBF4 was added until saturation of
the solution, which led to a yellow precipitate. Then the
suspension was centrifuged, the solid was dissolved in 10 ml of
dry acetonitrile, and filtered on celite to eliminate the excess of
NaBF4. After evaporation of the solvent, the tetrafluoroborate
salt was obtained as an orange-yellow powder.
[(C6H6)Ru(L
2)(OH2)][BF4] ([4][BF4]). (Yield: 60%, 97 mg).
1H NMR d (400 MHz, D2O, 21 uC) = 1.32–1.45 (m, 1H), 1.51–
1.62 (m, 2H), 2.27 (s, 3H), 2.62 (m, 2H), 2.88–2.91 (m, 1H),
3.14–3.21 (m, 1H), 5.62 (s, 6H), 7.21 (d, J = 8.1 Hz, 2H), 7.55
(d, J = 8.0 Hz, 2H) ppm. 13C NMR d (200 MHz, D2O, 21 uC) =
21.32 (CH3), 25.42 (CH2), 28.56 (CH2), 46.11 (CH2), 46.56
(CH2), 58.21 (CH), 83.36 (C6H6), 127.18 (CHarom.), 129.78
(CHarom.), 137.06 (Carom.), 143.21 (Carom.) ppm. m/z (ESI,
positive ion) 451 [C18H25N2O3RuS
+]. (Found: C, 40.31; H,
4.73; N, 5.26. C18H25BF4N2O3RuS requires C, 40.23; H, 4.69;
N, 5.21).
[(p-MeC6H4
iPr)Ru(L2)(OH2)][BF4] ([5][BF4]). (Yield: 58%,
107 mg). 1H NMR d (400 MHz, D2O, 21 uC) = 1.12 (d, J =
6.8 Hz, 6H), 1.29–1.37 (m, 1H), 1.54–1.61 (m, 2H), 1.97 (s,
3H), 2.32 (s, 3H), 2.52 (m, 2H), 2.63 (m, 1H), 2.92–2.99 (m,
1H), 3.15–3.23 (m, 1H), 5.61(d, J = 6.2 Hz, 2H), 5.78 (d, J =
6.2 Hz, 2H), 7.24 (d, J = 8.0 Hz, 2H), 7.55 (d, J = 8.1 Hz, 2H)
ppm. 13C NMR d (200 MHz, D2O, 21 uC) = 19.04 (CH3), 21.32
(CH3), 22.44 ((CH3)2), 25.42 (CH2), 27.38 (CH), 28.56 (CH2),
46.11 (CH2), 46.56 (CH2), 58.21 (CH), 86.31 (CHarom.), 88.28
(CHarom.), 106.13 (Carom.), 107.08 (Carom.), 127.05 (CHarom.),
129.85 (CHarom.), 137.12 (Carom.), 143.18 (Carom.) ppm. m/z
(ESI, positive ion) 507.1 [C22H33N2O3RuS
+]. (Found: C,
44.45; H, 5.71; N, 4.57. C22H33BF4N2O3RuS requires C,
44.53; H, 5.60; N, 4.72).
[(C6Me6)Ru(L
2)(OH2)][BF4] ([6][BF4]). (Yield: 61%, 112 mg).
1H NMR d (400 MHz, D2O, 21 uC) = 1.33–1.42 (m, 1H), 1.57–
1.64 (m, 2H), 1.98 (s, 18H), 2.28 (s, 3H), 2.57 (dd, J = 5.1 Hz,
J = 5.8 Hz, 2H), 2.91–2.96 (m, 1H), 3.17–3.28 (m, 1H), 7.26 (d,
J = 8.2 Hz, 2H), 7.57 (d, J = 8.2 Hz, 2H) ppm. 13C NMR d
(200 MHz, D2O, 21 uC) = 15.18 (C6(CH3)6), 21.32 (CH3),
25.42 (CH2), 28.56 (CH2), 46.11 (CH2), 46.56 (CH2), 58.21
(CH), 92.05 (C6(CH3)6), 127.18 (CHarom.), 129.78 (CHarom.),
137.06 (Carom.), 143.21 (Carom.) ppm. m/z (ESI, positive ion)
535.2 [C24H37N2O3RuS
+]. (Found: C, 46.41; H, 6.08; N, 4.48.
C24H37BF4N2O3RuS requires C, 46.38; H, 6.00; N, 4.51).
[(C6Me6)Ru(L
3)(OH2)][BF4] ([7][BF4]). (Yield: 59%, 132 mg).
1H NMR d (400 MHz, D2O, 21 uC) = 1.18 (s, 6H), 1.20 (s, 3H),
1.23 (s, 9H), 1.25 (m, 1H), 1.44 (m, 2H), 1.87 (s, 18H), 2.48 (m,
2H), 2.82 (m, 2H), 2.89 (m, 1H), 3.16–3.21 (m, 1H), 3.31 (m,
1H), 7.10 (s, 2H) ppm. 13C NMR d (200 MHz, D2O, 21 uC) =
15.03 (C6(CH3)6), 23.31 (CH3), 25.42 (CH2), 25.78 (CH3),
28.56 (CH2), 29.56 (CH), 34.15 (CH), 46.11 (CH2), 46.56
(CH2), 58.21 (CH), 92.12 (C6(CH3)6), 123.56 (CHarom.),
134.25 (CHarom.), 150.15 (Carom.), 152.32 (Carom.) ppm. m/z
(ESI, positive ion) 647.3 [C32H53N2O3RuS
+]. (Found: C,
52.21; H, 7.39; N, 3.78. C32H53BF4N2O3RuS requires C,
52.38; H, 7.28; N, 3.82).
[(p-MeC6H4
iPr)Ru(L4)(OH2)][BF4] ([8][BF4]). (Yield: 60%,
118 mg). 1H NMR d (400 MHz, D2O, 21 uC) = 1.02 (s, 3H),
1.11 (s, 3H), 1.12 (d, J = 6.8 Hz, 6H), 1.21 (b, 1H), 1.67–1.99
(b, 9H), 1.97 (s, 3H), 2.63 (m, 1H), 2.71–2.79 (b, 1H), 3.26–3.30
(b, 4H), 3.84 (b, 1H), 5.61(d, J = 6.2 Hz, 2H), 5.78 (d, J =
6.2 Hz, 2H) ppm. 13C NMR d (200 MHz, D2O, 21 uC) = 19.04
(CH3), 19.28 (CH3), 19.89 (CH3), 22.44 ((CH3)2), 25.48 (CH2),
27.01 (CH2), 27.10 (CH2), 27.38 (CH), 28.79 (CH2), 31.62
(CH), 42.71 (C(CH3)2), 42.85 (CH2CO), 46.12 (CH2), 46.53
(CH2), 49.88 (CH2SO2), 57.96 (CH), 59.27 (CCH2),
86.31 (CHarom.), 88.28 (CHarom.), 106.13 (Carom.), 107.08
(Carom.), 217.03 (CO) ppm. m/z (ESI, positive ion): = 567.2
[C25H41N2O4RuS
+]. (Found: C, 45.81; H, 6.40; N, 4.32.
C25H41BF4N2O4RuS requires C, 45.94; H, 6.32; N, 4.29).
[(C6Me6)Ru(L
4)(OH2)][BF4] ([9][BF4]). (Yield: 62%, 122 mg).
1H NMR d (400 MHz, D2O, 21 uC) = 1.02 (s, 3H), 1.11 (s, 3H),
1.21 (b, 1H), 1.67–1.99 (b, 9H), 2.01 (s, 18H), 2.71–2.79 (b, 1H),
3.26–3.30 (b, 4H), 3.84 (b, 1H) ppm. 13C NMR d (200 MHz,
D2O, 21 uC) = 15.15 (C6(CH3)6), 19.28 (CH3), 19.89 (CH3),
25.48 (CH2), 27.01 (CH2), 27.10 (CH2), 28.79 (CH2), 31.62
(CH), 42.71 (C(CH3)2), 42.85 (CH2CO), 46.12 (CH2), 46.53
(CH2), 49.88 (CH2SO2), 57.96 (CH), 59.27 (CCH2), 92.11
(C6(CH3)6), 217.03 (CO) ppm. m/z (ESI, positive ion) 595.2
[C27H45N2O4RuS
+]. (Found: C, 47.46; H, 6.54; N, 4.13.
C27H45BF4N2O4RuS requires C, 47.58; H, 6.65; N, 4.11).
Transfer hydrogenation catalysis
The transfer hydrogenation reactions of aryl ketones A1 to
A3 and aryl imines A4 to A6 (1 mmol), using 1 to 9 as
tetrafluoroborate salts (10 mmol) as catalyst and HCOONa
(5 mmol) as hydrogen source, were carried out in water (5 mL)
under inert atmosphere. In a typical experiment, the solution
6
was heated for 2 hours at 60 uC, then the reaction was
quenched by cooling to 0 uC. The organic products were
extracted by Et2O and identified after filtration through silica
gel by HPLC on Chiracel OB-H capillary column for aryl
ketones A1 to A3 (hexane–isopropanol = 92 : 8, 0.7 mL min21,
215 nm) and on Chiracel OD-H capillary column for
aryl imines A4 to A6 (hexane–isopropanol–diethylamine =
90 : 10 : 0.1, 1 mL min21, 230 nm). Conversion and enantio-
selectivity were determined by integration of the signals. The
pH was monitored using a pH meter (Mettler Toledo InLab1
413) and adjusted using HNO3 (for pH = 4 to 9) or NaOH (for
pH = 10).
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